Intravenous immunoglobulin in the treatment of Guillain-Barre syndrome

Elevli M.Yaramis A.Soker M.Haspolat K.Gunbey S.2024-04-242024-04-2419971300-0144https://hdl.handle.net/11468/24542[No abstract available]eninfo:eu-repo/semantics/closedAccessGuillain-Barre Syndromeİntravenous İmmunoglobulin (Ivıg)Intravenous immunoglobulin in the treatment of Guillain-Barre syndromeIntravenous immunoglobulin in the treatment of Guillain-Barre syndromeArticle2711031042-s2.0-0031045384Q1